ENCOMS: Argentinian survey in cost of illness and unmet needs in multiple sclerosis

The objective of the study was to assess the cost of multiple sclerosis (MS) patients in Argentina categorized by disease severity using a societal perspective. Cross-sectional study including MS patients from 21 MS centers in 12 cities of Argentina. Patients were stratified by disease severity usin...

Full description

Saved in:
Bibliographic Details
Published in:Arquivos de neuro-psiquiatria Vol. 72; no. 5; pp. 337 - 343
Main Authors: Ysrraelit, Celica, Caceres, Fernando, Villa, Andres, Marcilla, Marcela Parada, Blanche, Jorge, Burgos, Marcos, Parera, Ignacio Casas, Colombo, Oscar, Crespo, Ernesto, Deri, Norma, Labal, Patricio, Maluendez, Monica, Martinez, Alejandra, Melcon, Mario, Nofal, Pedro, Reich, Edgardo, Sinay, Vladimiro, Tarulla, Adriana, Vetere, Santiago, Barboza, Andres, Rey, Roberto, Moreno, Margarita, Bacile, Alejandra, Rojas, Juan I, Kuperman, Gaston, Resk, Mercedes, Seifer, Gustavo, Machinicki, Gerardo, Cuneo, Jorge
Format: Journal Article
Language:English
Published: Brazil Academia Brasileira de Neurologia - ABNEURO 01-05-2014
Academia Brasileira de Neurologia (ABNEURO)
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The objective of the study was to assess the cost of multiple sclerosis (MS) patients in Argentina categorized by disease severity using a societal perspective. Cross-sectional study including MS patients from 21 MS centers in 12 cities of Argentina. Patients were stratified by disease severity using the expanded disability status scale (EDSS) (group 1 with EDSS score between 0 and 3; group 2 with EDSS >3 and <7; group 3 with EDSS ≥7). Direct and indirect costs were analyzed for the second quarter of 2012 from public sources and converted to US Dollars. 266 patients were included. Mean annual cost per MS patient was USD 36,025 (95%CI 31,985-38,068) for patients with an EDSS between 0-3; USD 40,705 (95%CI 37,199-46,300) for patients with EDSS >3 and <7, and USD 50,712 (95%CI 47,825-62,104) for patients with EDSS ≥7. This is the first Argentine study evaluating the costs of MS considering disease severity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0004-282X
1678-4227
1678-4227
0004-282X
DOI:10.1590/0004-282X20140016